| Jessica Keusch, MD | |
|
2547 Park Pl, Bellmore, NY 11710-4505 | |
| (917) 371-8497 | |
| Not Available |
| Full Name | Jessica Keusch |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 2547 Park Pl, Bellmore, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245491737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 240398-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White Plains Hospital Center | White plains, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westchester Medical Group Pc | 6406752963 | 405 |
| North American Partners In Anesthesia Llp | 7719885771 | 503 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | Rockville Anesthesia Group, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841303997 PECOS PAC ID: 9537071873 Enrollment ID: O20031104000508 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | Westchester Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881653822 PECOS PAC ID: 6406752963 Enrollment ID: O20031208000533 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | Long Island Anesthesia Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952387276 PECOS PAC ID: 7113825381 Enrollment ID: O20040106000103 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | Westchester Anesthesiologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366472243 PECOS PAC ID: 0749170736 Enrollment ID: O20040315001575 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | The Rye Ambulatory Surgery Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578892600 PECOS PAC ID: 5597896985 Enrollment ID: O20100629000500 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Keusch, MD 2547 Park Pl, Bellmore, NY 11710-4505 Ph: () - | Jessica Keusch, MD 2547 Park Pl, Bellmore, NY 11710-4505 Ph: (917) 371-8497 |
News Archive
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
Almirall, S.A. has launched today AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health.
The American Academy of Pediatrics recommends that pediatric healthcare providers promote active healthy living by encouraging children to play outside as much as possible. Being outdoors correlates strongly with physical activity for children, which is important for preventing obesity in the preschool years and on through adulthood.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 7 days ago